The hIL-15TgNSG mice were generated as previously described56 (link)–58 (link). All mice experiments were approved by the Wistar Institute Animal Care and Research Committee (protocol no. 201360). All animals recruited in the present study were housed in the Wistar Institute humanized mice holding room with a 12-h light:dark cycle at temperatures of 20–23 °C and 40–60% humidity. Briefly, 6- to 8-week-old female NSG-Tg(hIL-15) (NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(IL15)1Sz/SzJ; Jackson Laboratory59 (link)) mice were pretreated with busulfan at 30 mg kg−1 and were then implanted with human fetal thymic tissue fragments and fetal liver tissue fragments under the murine renal capsule. After the surgery, mice were injected via the tail vein with CD34+ hematopoietic stem cells isolated from human fetal liver tissues. Human fetal liver and thymus tissues were procured from Advanced Bioscience Resources. Then 12 weeks postsurgery, human immune cell reconstitution in peripheral blood was determined using a FACSymphony flow cytometer (BD Biosciences) using the following antibodies (1:50 dilution): mCD45-AF700, hCD45-FITC, hCD3-BUV805, hCD4-BUV395, hCD8-PerCP-Cy5.5, hCD56-BV650 and Fixable Viability Stain 510 (catalog nos. 560510, 555482, 612895, 563550, 565310, 564057 and 564406, respectively; BD Biosciences). Data were analyzed with FlowJo.
Free full text: Click here